Saadia Bashir Hassan
Division of Clinical Pharmacology
Department of Medical Sciences
University Hospital
751 85 Uppsala
Sweden
Name/email consistency: high
- Alpha terpineol: a potential anticancer agent which acts through suppressing NF-kappaB signalling. Hassan, S.B., Gali-Muhtasib, H., Göransson, H., Larsson, R. Anticancer Res. (2010)
- Primary lymphocytes as predictors for species differences in cytotoxic drug sensitivity. Hassan, S.B., Haglund, C., Aleskog, A., Larsson, R., Lindhagen, E. Toxicol. In. Vitro (2007)
- CHS 828 kill tumour cells by inhibiting the nuclear factor-kappaB translocation but unlikely through down-regulation of proteasome. Hassan, S.B., Lövborg, H., Lindhagen, E., Karlsson, M.O., Larsson, R. Anticancer Res. (2006)
- Cytotoxic activity of a new paclitaxel formulation, Pacliex, in vitro and in vivo. Hassan, S., Dhar, S., Sandström, M., Arsenau, D., Budnikova, M., Lokot, I., Lobanov, N., Karlsson, M.O., Larsson, R., Lindhagen, E. Cancer Chemother. Pharmacol. (2005)
- A hollow fiber model for in vitro studies of cytotoxic compounds: activity of the cyanoguanidine CHS 828. Hassan, S.B., de la Torre, M., Nygren, P., Karlsson, M.O., Larsson, R., Jonsson, E. Anticancer. Drugs (2001)
- Model for time dependency of cytotoxic effect of CHS 828 in vitro suggests two different mechanisms of action. Hassan, S.B., Jonsson, E., Larsson, R., Karlsson, M.O. J. Pharmacol. Exp. Ther. (2001)